Global Point-of-Care Infectious Disease Diagnostics & Testing market cagr 9.9%

Point-of-Care Infectious Disease Diagnostics & Testing Market

Point-of-Care Infectious Disease Diagnostics & Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Point-of-Care Infectious Disease Diagnostics & Testing

Market Size and Growth

The global Point-of-Care Infectious Disease Diagnostics & Testing market is projected to reach a value of $3.9 billion by 2025. This growth is attributed to increasing demand for rapid and accurate diagnostic tools, rising prevalence of infectious diseases, and advancements in technology. Key players in the market include Roche Diagnostics, Abbott Laboratories, and Danaher Corporation.

Companies Covered (Covid 19 Impact Covered)

◍ Abbott

◍ Thermo Fisher Scientific Inc

◍ Roche

◍ Siemens Healthineers

◍ BD & Company

◍ Chembio Diagnostics Inc.

◍ Trinity Biotech

◍ Cardinal Health

◍ Quest Diagnostics Inc.

◍ Bio-Rad Labs Inc.

◍ bioMérieux SA

◍ Sight Diagnostics Ltd.

◍ Gene POC

◍ Trivitron Healthcare

◍ OJ-Bio Ltd.

◍ Ortho-Clinical Diagnostics

The Point-of-Care Infectious Disease Diagnostics & Testing Market is highly competitive with key players like Abbott, Thermo Fisher Scientific, Roche, and Siemens Healthineers dominating the market. These companies offer a range of innovative testing solutions to aid in the rapid diagnosis and management of infectious diseases, contributing to the growth of the market.

- Abbott: $34.6 billion in sales revenue

- Roche: $61.4 billion in sales revenue

- Thermo Fisher Scientific: $31.9 billion in sales revenue

Market Segmentation

By Application By Product

◍ Hospitals

◍ Clinics

◍ Home

◍ Assisted Living Healthcare Facilities

◍ Laboratories

◍ Others

◍ HIV POC

◍ Clostridium difficile POC

◍ HBV POC

◍ Pneumonia or Streptococcus associated infections

◍ Respiratory syncytial virus (RSV) POC

◍ HPV POC

◍ Influenza/Flu POC

◍ Other Infectious Disease POC